Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000420 · ClinicalTrials.gov registry record · Phase 3
Safety of Estrogens in Lupus: Birth Control Pills
A Phase 3 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 3
- Development phase
- 350
- Enrollment target
NCT00000420 is a Phase 3 study that has completed, run by NYU Langone Health. The registered enrollment target is 350 participants.
The verdict
NCT00000420, a Phase 3 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 350 participants
- Enrollment target
Study Summary
Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA) is a study to test whether women with systemic lupus erythematosus (SLE or lupus) can safely use estrogen. We will determine this by looking at the effects of oral contraceptives (birth control pills, also known as "the pill") on disease activity and severity in women with SLE. The results of the study will show whether it is safe for women with SLE to use the pill.
Interventions
- DRUG Ortho-Novum 777
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 1997-06 |
| Est. Completion | 2003-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000420
The ClinicalTrials.gov registry entry for NCT00000420 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ortho-Novum 777 is the first listed.
NCT00000420 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000420 about?
NCT00000420 is a clinical study titled "Safety of Estrogens in Lupus: Birth Control Pills". Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA) is a study to test whether women with systemic lupus erythematosus (SLE or lupus) can safely use estrogen. We will determine this by looking at the effects of oral contraceptives (birth control pills, also known as "the pill")...
What is the current status of trial NCT00000420?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 350 participants. The study started on 1997-06. Estimated completion is 2003-08.
What interventions are being tested in trial NCT00000420?
The interventions under investigation include: Ortho-Novum 777 (DRUG).
Who is sponsoring clinical trial NCT00000420?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.